Distinct properties of the recognition sites for beta-very low density lipoprotein (remnant receptor) and alpha 2-macroglobulin (low density lipoprotein receptor-related protein) on rat parenchymal cells

J Biol Chem. 1992 Sep 5;267(25):17732-7.

Abstract

The properties of the recognition sites for alpha 2-macroglobulin (alpha 2-macroglobulin receptor; low density lipoprotein receptor-related protein) and beta-migrating very low density lipoprotein (beta-VLDL) (remnant receptor) on rat parenchymal cells were directly compared to analyze whether both substrates are recognized and internalized by the same receptor system. In cholesterol-fed rats, the large circulating pool of beta-VLDL is unable to diminish the liver uptake of 125I-labeled alpha 2-macroglobulin, while liver uptake of 125I-labeled beta-VLDL in these rats is reduced by 87.3% at 10 min after injection. In vitro competition studies with isolated parenchymal liver cells demonstrate that the binding of 125I-labeled alpha 2-macroglobulin to rat parenchymal cells is not effectively competed for by beta-VLDL, whether this lipoprotein is additionally enriched in apolipoprotein E or not. Binding of alpha 2-macroglobulin to parenchymal cells requires the presence of calcium, while binding of beta-VLDL does not. Incubation of parenchymal cells for 1 h with proteinase K reduced the subsequent binding of alpha 2-macroglobulin by 90.1%, while the binding of beta-VLDL was reduced by only 20.2%. In the presence of monensin, the association of alpha 2-macroglobulin to parenchymal cells at 2 h of incubation was reduced by 64.7%, while the association of beta-VLDL was not affected. Preincubation of parenchymal cells with monensin for 60 min at 37 degrees C reduced the subsequent binding of alpha 2-macroglobulin by 54.5%, while binding of beta-VLDL was only reduced by 14.6%. The results indicate that the recognition sites for alpha 2-macroglobulin and beta-VLDL on rat parenchymal cells do exert different properties and are therefore likely to reside on different molecules.

MeSH terms

  • Animals
  • Apolipoproteins E / metabolism
  • Binding Sites
  • Calcium / pharmacology
  • Cholesterol, Dietary / pharmacology
  • Egtazic Acid / pharmacology
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Lipoproteins, VLDL / metabolism*
  • Liver / cytology
  • Liver / drug effects
  • Liver / metabolism*
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Male
  • Monensin / pharmacology
  • Rats
  • Rats, Inbred Strains
  • Receptors, Immunologic / drug effects
  • Receptors, Immunologic / metabolism*
  • Receptors, LDL / drug effects
  • Receptors, LDL / metabolism*
  • alpha-Macroglobulins / metabolism*

Substances

  • Apolipoproteins E
  • Cholesterol, Dietary
  • Lipoproteins, VLDL
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Receptors, Immunologic
  • Receptors, LDL
  • VLDL receptor
  • alpha-Macroglobulins
  • Egtazic Acid
  • Monensin
  • Calcium